Generics

Fresenius Kabi intros generic Tepadina

Generic Tepadina has multiple indications, including for the treatment of patients with adenocarcinoma of the breast or ovary.
AAM elevates David Gaugh to EVP of sciences, regulatory affairs

Gaugh joined the Association for Accessible Medicines in 2012 as senior vice president of sciences and regulatory affairs.
Aurobindo receives FDA OK for generic Letairis

Generic Letairis is indicated for the treatment of pulmonary arterial hypertension (WHO Group 1) and also is used in combination with tadalafil.
Dr. Reddy’s debuts generic Velcade

Velcade is used to treat adults with multiple myeloma, a cancer of the plasma cells. It also is used to treat adults with mantle cell lymphoma, a cancer of the lymph nodes.
Apotex offers generic Eliquis in Canada

Apotex's apixaban is an oral anticoagulant indicated for the prevention and treatment of harmful blood clots.
U.S. Court of Appeals for the Federal Circuit affirms validity of Tris Pharma’s Quillivant XR patents

Actavis is prohibited from launching a generic version of Quillivant XR until the expiration of the patent portfolio providing exclusivity in February 2031.
Lupin receives FDA OK for generic Edarbi

Generic Edarbi is used to treat high blood pressure.
Sun Pharma, Cassiopea expand license, supply agreement for Winlevi

Sun Pharma and Cassiopea will bring Winlevi to patients in Japan, Australia, New Zealand, Brazil, Mexico and Russia.

Dr. Reddy’s inks licensing agreement with Slayback for Lumify OTC